Day: May 6, 2022

ALLEN, Texas, May 06, 2022 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW) (the “Company”), a global commerce services company, will hold a conference call on Tuesday, May 10, 2022 at 8:30 a.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2021. The results will be reported in a press release prior to the conference call. PFSweb management will host the conference call, followed by a question and answer period. Date: Tuesday, May 10, 2022Time: 8:30 a.m. Eastern time (5:30 a.m. Pacific time)Toll-free dial-in number: (800) 584-2088International dial-in number: (212) 231-2931Conference ID: 22018684 Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the...

CASTLE ROCK, Colo., May 06, 2022 (GLOBE NEWSWIRE) — Where Food Comes From, Inc. (WFCF) (Nasdaq: WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, today announced it will release its 2022 first quarter financial results before the market opens on Thursday, May 12, 2022, and conduct a conference call the same day at 10:00 a.m. Mountain Time (12:00 p.m. Eastern). Dial-in numbers for the conference call: Domestic Toll Free: 1-877-407-8289 International: 1-201-689-8341 Conference Code: 13729885 Phone replay: A telephone replay of the conference call will be available through June 9, 2022, as follows: Domestic Toll Free: 1-877-660-6853 International: 1-201-612-7415 Conference Code: 13729885 About Where Food Comes From, Inc. Where Food Comes From, Inc. is...

SCOTTSDALE, AZ, May 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire –RAADR, Inc. (OTC PINK: RDAR), a technology and software development company that monitors cyber-bullying and social media platforms with artificial intelligence, announced today that it has formed an athletic advisory panel to assist management on how to utilize current and retired professional athletes to market RAADR’s corporate mission to combat bullying using its RAADR Parental Monitoring App 2.0. The inaugural member of the advisory panel is social media sensation and basketball legend Larry Williams. Mr. Williams currently has over 1.4 million social media followers. Mr. Williams is internationally known as the “Bone Collector” and is often recognized as one of the most skilled basketball players in the world. Mr. Williams has worked with RAADR since...

LOS ANGELES and KINGSTON, Jamaica, May 06, 2022 (GLOBE NEWSWIRE) — NUGL Inc. (“NUGL”) (OTC: NUGL), a global cannabis lifestyle brand and technology-based multimedia platform, announced today Arnold “Bigg A” White and Eric “Lil Eazy-E” Wright of Rich & Ruthless have extended their broadcasting agreement with NUGL TV. Bigg A, along with co-host Jessica Serrano, will host a biweekly program covering the cannabis community’s top trends in music, fashion, and product featuring celebrity and insider interviews, product and strain reviews, as well as featured canna-businesses. Lil Eazy-E recently launched his own show on NUGL TV, which is presented by Kaya Herb House. Last month NUGL acquired Kaya Herb House in an all-stock transaction and plans to leverage Rich & Ruthless’s reach to develop the Kaya brand...

NEWTON, Mass. and GENEVA, May 06, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (“Relief”), today announced the presentation of data evaluating the bioavailability, bioequivalence and taste attributes of ACER-001 (sodium phenylbutyrate) compared to sodium phenylbutyrate (BUPHENYL®) powder during poster sessions at the recent Genetic Metabolic Dieticians International (GMDI) Conference on May 5, 2022, in Las Vegas, Nevada. “We are pleased to present results from these two studies at another renowned genetic metabolic conference,” said Adrian Quartel, MD, CMO of Acer. “These data further support our belief that, if approved, ACER-001 could offer an alternative to current therapies that may lead to meaningful clinical...

BEIJING, May 06, 2022 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today provided an update on its status under the Holding Foreign Companies Accountable Act (the “HFCAA”). The Company was provisionally identified as a Commission-Identified Issuer by the United States Securities and Exchange Commission (the “SEC”) on May 4, 2022 under the HFCAA and its implementation rules issued thereunder, following the Company’s filing of its annual report on Form 20-F for the year ended December 31, 2021 with the SEC on April 26, 2022. The Company understands that such identification indicates that the SEC determined that the Company engaged...

ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced that an interview with Chief Operating Officer, Jason Grady, will air on The RedChip Money Report® on Bloomberg U.S., this Saturday May 7th, at 7 p.m. Eastern Time (ET). Bloomberg U.S. is available in an estimated 73 million homes across the United States. The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years’ experience focused on Discovering Tomorrow’s Blue Chips Today™. “The RedChip Money Report®” delivers insightful commentary...

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech,” or the “Company”), announced that its private placement of up to 10,000,000 common shares (“Shares”) at a price of $0.10 per Share for aggregate gross proceeds of up to $1,000,000, as previously announced on March 15, 2022 (the “Private Placement”), has been fully subscribed and is anticipated to close on May 16, 2022. Certain insiders of the Company are participating in the private placement, including Marc Edwards, the CEO of the Company. Mr. Edwards has agreed to purchase 3,100,000 Shares at a price of $0.10 per share for a total purchase price of $310,000. “I am excited to personally participate in this Private Placement as I saw...

CARLSBAD, Calif., May 06, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,646,690 shares of its common stock, at a purchase price of $0.55 per share. Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering. The closings of the sale of the securities in the financing is expected to occur on or about May 10, 2022, subject to the satisfaction of customary closing conditions. Palisade Bio intends to use the net proceeds from the financing for working capital and...

WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three months ended March 31, 2022 before the opening of the U.S. financial markets on Friday, May 13, 2022 and will hold a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions. Conference Call and Webcast InformationEvent: Biofrontera Inc. First Quarter 2022 Financial Results and Business Update Conference CallDate: Friday, May 13, 2022Time: 11:00 a.m. Eastern timeConference call: 1-877-877-1275 (U.S.)1-412-858-5202 (international)Webcast: Live and 90-day replay webcast are available here and at www.investors.biofrontera-us.com.   About...